logo
logo
Sign in
Avani Sable
Followers 1 Following 0
Avani Sable 2021-10-22
img

The global contraceptive pills market size is projected to reach USD 20.55 billion by 2026, exhibiting a CAGR of 5.8% during the forecast period.

High degree of unfulfilled contraceptive needs in rural areas in emerging economies is expected to be one of the key drivers for the growth of this market.

Data gathered under the Demographic and Health Surveys (DHS) conducted between 2005 and 2014 in 52 developing countries revealed that around 8% to 38% of married rural women, aged between 15 and 49 years, faced unmet contraceptive needs.

The main reason for this gap is the lack of accessibility and local availability of birth-control pills in these areas.

To counter this, governments in many developing and underdeveloped countries are taking efforts to make these modern day medications more accessible and affordable to the rural populace.

This will effectively accelerate the oral contraceptives market growth during the forecast period.For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/contraceptive-pills-market-101802 Fortune Business Insights™, in its report, titled “Contraceptive Pills Market Size, Share & Industry Analysis, By Type (Combination Pills and Progestin-only Pills), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel & NGO, and Others) and Regional Forecast, 2019-2026”, states that the value of this market stood at USD 13.11 billion in 2018.

collect
0
Avani Sable 2021-10-20
img

The global medical lasers market will witness considerable growth due to growing applications of medical lasers in surgical procedures.

According to a report published by Fortune Business Insights, titled “Medical Lasers: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 3,778.9 Mn in 2018.

Fortune Business Insights has predicted that the market will reach US$ 12,327.8 Mn by 2026, thereby exhibiting a CAGR of 15.9%.For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/medical-lasers-market-101071The ability of medical lasers to treat damaged or targeted tissues, through a minimally invasive procedure, has led to a huge demand across the world.

Medical lasers possess the ability to diagnose and treat several diseases, which in turn will lead to a rising adoption across the world.

The use of laser radiation comes with certain challenges; recent scientific advancements will favor the growth of the global medical lasers market in the forthcoming years.

Resulting from the high demand, there have been numerous technological advancements in the manufacture of these equipment and this, according to Fortune Business Insights will constitute an increase in the global medical lasers market value in the forthcoming years.

collect
0
Avani Sable 2021-10-18
img

The rapid adoption of electronic medical records and electronic health records by companies across the world drives the global revenue cycle management market or RCM market.

Fortune Business Insights in its new report, titled “Revenue Cycle Management: Global Market Analysis, Insights and Forecast 2018-2025” predicts the market to grow at a remarkable rate during the forecast period.

North America is expected to contribute significantly towards the growth of the revenue cycle management market.Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/revenue-cycle-management-market-100275Some of the major companies that are present in the Global Revenue Cycle Management Market are;MicrosoftIBMDellMcKessonExperianAllscriptsAthenahealthGreenway HealthGeBBS Healthcare SolutionsZirMed, now part of WaystarEpic Systems CorporationGeneral Electric Manufacturing Company Cerner CorporationThe rising adoption of RCM among end users and presence of well-established healthcare infrastructure is expected to drive the RCM market in North America.

In addition to this, revenue cycle management solutions offer long-term benefits, which is a key reason behind its high uptake in the region.

Furthermore, the increasing presence of physicians and hospitals in North America will fuel the demand for revenue cycle management services in the coming years.According to studies, Asia Pacific is projected to exhibit a high growth in the global RCM market.

The growth is primarily attributable to the rising target population looking for medical claims and treatment.

collect
0
Avani Sable 2021-10-13
img

The increasing prevalence of respiratory diseases and alpha-1 antitrypsin deficiency among people worldwide is boosting the global plasma fractionation market, says Fortune Business Insights in a new study.

The report, titled “Plasma Fractionation: Global Market Analysis, Insights, and Forecasts 2018 to 2026,” offers insights into growth drivers and restraints impacting the plasma fractionation market.Browse Complete Report:https://www.fortunebusinessinsights.com/industry-reports/plasma-fractionation-market-101614Rise in Number of Diagnostic Centers for using Plasma Proteins as Therapeutics to Bode Well for MarketThe rising awareness about diseases because of the expansion of media and increasing number of diagnostic centers have increased the value of plasma fractionation.

This is a major factor boosting the overall market.

In addition to that, increasing investments made in designing of therapeutics for chronic diseases is also anticipated to drive the global market.

Besides this, the increasing popularity and usage of proteins derived from plasma for various treatments is presumed to bode well for the global market.However, high cost of fractionation and insufficient reimbursement policies may cause hindrance to the growth of the market.

This, accompanied by the emergence of recombinant alternatives may hamper the market in the long run.North America Emerges Dominant on Account of Better Healthcare InfrastructuresGeographically, the global market for plasma fractionation is dominated by North America at present.

collect
0
Avani Sable 2021-10-22
img

The global contact lenses market size is projected to reach USD 12.05 billion by 2026, exhibiting a CAGR of 4.8% during the forecast period.

However, the market was worth USD 8.35 billion in 2018.

This information is published in a recent report by Fortune Business Insights, titled, “Contact Lenses Market Size, Share & Industry Analysis, By Modality (Reusable and Disposable), By Design (Toric, Multi-Focal, and Spherical), By Distribution Channel (Retail Stores, Online Stores, and Ophthalmologists), and Regional Forecast, 2019-2026.” As per the report, rising per capita healthcare expenditure and increasing incidence of astigmatism and myopia are expected to affect the market positively.For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/contact-lenses-market-101775What Does the Report Contain?In-depth information regarding all the possible segments, including modality, design, distribution channel, and region.Elaborate analysis of several insights, namely, contact lenses market trends, opportunities, growth drivers, and hindrances.Latest industry developments, such as new product launches, mergers, acquisitions, partnerships, and agreements.Rising Prevalence of Ocular Disorders to Augment Market GrowthThe World Health Organization (WHO) stated that approximately 1.7 million people are affected by presbyopia and around 153 million people reside with uncorrected refractive errors around the world.

A rising prevalence of presbyopia worldwide is one of the main factors propeling the contact lenses market growth in the coming years.

Also, many people are affected by ocular disorders, which in turn, is expected to boost growth of the market.Spherical Segment to Dominate the Market Backed by High PrescriptionsIn terms of design, the market is segregated into spherical, multifocal, and toric.

Out of these, the spherical segment had generated 65.8% contact lenses market share in 2018 and was in the leading position.

collect
0
Avani Sable 2021-10-20
img

The global psoriasis treatment market size is anticipated to touch USD 37,634.2 million by 2026 owing to the increasing number of psoriasis cases.

These include non-melanoma skin cancer, psoriatic arthritis, lung cancer, depression, metabolic syndrome, cardiac disorders, COPD (chronic obstructive pulmonary disease), and others.

It may also cause polycystic ovarian syndrome and pregnancy complications in women.

As per this report titled, “Psoriasis Treatment Market Size, Share and Industry Analysis By Drug Class (TNF Inhibitors, Interleukins, Others), By Type (Plaque Psoriasis, Psoriatic Arthritis, Others), By Route of Administration (Oral, Parenteral, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online pharmacies), and Regional Forecast 2019-2026,” According to this report, the market value stood at USD 18,378.0 million in 2018 and will exhibit a CAGR of 9.4% between 2019 to 2026.visit: https://www.fortunebusinessinsights.com/industry-reports/psoriasis-treatment-market-100600The emergence of COVID-19 has brought the world to a standstill.

We understand that this health crisis has brought an unprecedented impact on businesses across industries.

Rising support from governments and several companies can help in the fight against this highly contagious disease.

collect
0
Avani Sable 2021-10-18
img

The global respiratory syncytial virus (RSV) therapeutics market size is estimated to showcase potential growth owing to its increasing adoption against the prevention and treatment of the disease, observes Fortune Business Insights™ in an upcoming report, titled, “Respiratory Syncytial Virus (RSV) Therapeutics Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Prophylaxis and Treatment), By End-user (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) and Regional Forecast, 2020-2027.” The respiratory syncytial virus (RSV) therapeutics market stood at USD 1,111.3 million in 2019.

It is projected to grow from USD 609.2 million in 2020 to USD 4,003.4 million in 2027 at a CAGR of 30.9% in the forecast period.For More Questions, Talk with Respiratory Syncytial Virus (RSV) Therapeutics Industry Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/respiratory-syncytial-virus-rsv-therapeutics-market-104668High Production Scale to Hinder Growth Opportunities in Global Pharmaceutical SpaceThe COVID-19 contagion is expected to drive the global pharmaceutical industry.

Enterprises across the world along with governments from several nations are contributing to the development and distribution of the vaccine.

However, the scale at which the production is assumed to take place is a major challenge for most of the renowned players.

At Fortune Business Insights™, we are providing actionable insights by closely studying multiple aspects of the current scenario.

We are also offering firsthand information on various market trends through our comprehensive research reports.New Product Launches from Key Players Helped Prophylaxis Segment Hold Largest Share In 2019Based on drug class, the prophylaxis segment led the market with the largest share in 2019.

collect
0
Avani Sable 2021-10-13
img

The increasing prevalence of respiratory diseases and alpha-1 antitrypsin deficiency among people worldwide is boosting the global plasma fractionation market, says Fortune Business Insights in a new study.

The report, titled “Plasma Fractionation: Global Market Analysis, Insights, and Forecasts 2018 to 2026,” offers insights into growth drivers and restraints impacting the plasma fractionation market.Browse Complete Report:https://www.fortunebusinessinsights.com/industry-reports/plasma-fractionation-market-101614Rise in Number of Diagnostic Centers for using Plasma Proteins as Therapeutics to Bode Well for MarketThe rising awareness about diseases because of the expansion of media and increasing number of diagnostic centers have increased the value of plasma fractionation.

This is a major factor boosting the overall market.

In addition to that, increasing investments made in designing of therapeutics for chronic diseases is also anticipated to drive the global market.

Besides this, the increasing popularity and usage of proteins derived from plasma for various treatments is presumed to bode well for the global market.However, high cost of fractionation and insufficient reimbursement policies may cause hindrance to the growth of the market.

This, accompanied by the emergence of recombinant alternatives may hamper the market in the long run.North America Emerges Dominant on Account of Better Healthcare InfrastructuresGeographically, the global market for plasma fractionation is dominated by North America at present.

collect
0
Avani Sable 2021-10-21
img

The global cosmeceuticals market size is projected to reach USD 73.73 billion by the end of 2026.

Increasing awareness among consumers regarding the advantages of cosmeceuticals over ordinary cosmetics will lead to a wider product adoption.According to a report published by Fortune Business Insights, titled “Cosmeceuticals Market Size, Share & Industry Analysis, By Product (Skin Care, Hair Care, Injectables and Others), By Distribution Channels (Pharmacy/Drug Stores, Online Stores, and Others), and Regional Forecast, 2019-2026,” the market was worth USD 37.41 billion in 2018 and will exhibit a CAGR of 8.9% during the forecast period, 2019-2026.For more information in the analysis of this report, visit:https://www.fortunebusinessinsights.com/cosmeceuticals-market-102521Product Overview:Cosmeceuticals are a combination of cosmetic product and pharmaceuticals.

They are mainly used in enhancing the physical appearance of the body and enhance skin health.

The demand for visually appealing lifestyle and changing habits will lead to a wider adoption of cosmeceuticals across the world.

The presence of several large scale vendors will emerge in favor of the growth of the overall cosmeceuticals market.

The availability of cosmeceuticals at a low cost will contribute to market growth.Little Optimism for SMEs; Extended Lockdowns Doing More Damage than Earlier PredictionsAs Covid-19 cases continue to rise, businesses are doing their best to adopt strategies that will help them run through online platforms, be it marketing or even distribution of the product.

collect
0
Avani Sable 2021-10-19
img

The global pressure ulcer (PU) treatment market is expected to gain momentum from the rising adoption of innovative wound care devices for treatment.

As per the Agency for Healthcare Research & Quality (AHRQ), in the U.S., more than 2.5 million people get affected by pressure ulcers annually.

It proves that the increasing geriatric population, coupled with upsurging cases of PU would affect the market positively in the coming years.For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/pressure-ulcer-treatment-market-102095This information is provided by Fortune Business Insights™ in a recent study, titled, “Pressure Ulcer (PU) Treatment Market Size, Share & Industry Analysis, By Ulcer Type (Stage 1, Stage 2, Stage 3, Stage 4), By Product (Wound-care Dressings, Wound-care Devices, and Others), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Homecare Settings), and Regional Forecast, 2019-2026.” The study further states that the pressure ulcer treatment market size is projected to reach USD 11.23 billion by 2026, thereby exhibiting a CAGR of 6.7% during the forecast period.

However, it stood at USD 6.69 billion in 2018.The Report Answers the Following Questions:What are the most vital pressure ulcer market trends, opportunities, and challenges?How many growth drivers and hindrances will the market face?Which region will remain at the forefront throughout the forecast period?Which segment will dominate in terms of share?What are the strategies adopted by renowned companies to increase sales?DriverRising Patent Pool Worldwide to Augment GrowthIn the 20th century, a pressure ulcer was considered to be one of the costliest and the most physically debilitating complications.

Factors, such as mobility problems, sedentary lifestyle, advancing age, and other similar health issues are mainly responsible for surging the incidence of PU worldwide.

The National Center for Biotechnology Information (NCBI) declared that in 2018, the prevalence of pressure ulcers in Ethiopia, Turkey, and Brazil was 16%, 10.4%, and 12.7%, respectively.

collect
0
Avani Sable 2021-10-14
img

The global compression therapy market size is projected to reach USD 4.51 billion by 2026, exhibiting a CAGR of 5.2% during the forecast period.

Rising prevalence of cancer will be a key growth driver for this market in the coming decade, finds Fortune Business Insights™ in its report, titled “Compression Therapy Market Size, Share and Industry Analysis By Product (Compression Garments {Compression Bandages, Compression Stockings, and Others}, Compression Pumps, and Others), By Application (Venous Leg Ulcer, Deep Vein Thrombosis (DVT), Lymphedema, and Others), By End User (Hospitals & Clinics, Nursing Care Centers, Home Care, and Others), and Regional Forecast, 2019-2026”.

The global disease burden of cancer, according to the International Agency for Research on Cancer (IARC), rose by an estimated 18.1 million new cases in 2018.For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/compression-therapy-market-102689Cancer therapy, especially for breast and prostate cancers, generally involves dissection of lymph nodes, which causes disruption in the filtering mechanism of the lymphatic system in the body.

As a result, lymph fluid accumulates and causes massive swelling of limbs or tissues, a condition known as lymphedema.

Worldwide prevalence of this condition, as reported by the National Institutes of Health, is around 250 million.

One of the most commonly used treatment options for lymphedema is compression therapy and with increasing incidence of this condition, the demand for these therapies is set to steadily rise.Healthy R Funding to Fuel the Market in North AmericaThe market size in North America stood at USD 1.05 billion in 2018 backed by concerted investment in healthcare research and development by the private and public sectors.

collect
0
Avani Sable 2021-10-12
img

The global bovine lactoferrin market size is projected to reach USD 949.0 million by the end of 2027.

Technological advancements in manufacturing processes will have a positive impact on the growth of the overall market in the coming years.

According to a report published by Fortune Business Insights, titled “Bovine Lactoferrin Market Size, Share & COVID-19 Impact Analysis, By Product (Spray-dried, and Freeze-dried), By Application (Infant Formula, Pharmaceuticals, Dietary Supplements, Food, and Others), and Regional Forecast, 2020-2027,” the market was worth USD 546.6 million in 2019 and will exhibit a CAGR of 5% during the forecast period, 2020-2027.For more Information: https://www.fortunebusinessinsights.com/industry-reports/bovine-lactoferrin-market-101656Lactoferrin is an anti-microbial that has the ability to fight severe diseases such as Crohn’s disease.

The product is said to boost the fight against intestinal ulcers and critical diseases such as hepatitis C. Accounting to its properties, lactoferrin is used to treat viral infections.

The substance is found in human milk like colostrum, the first milk produced after the baby is born.

Due to several advantages of the product with regard to human health, bovine lactoferrin is being studied on a wider scale across the world.

collect
0
Avani Sable 2021-10-21
img

The global e-prescribing market size is expected to touch USD 4,017.79 million by the end of 2026, attributable to the incorporation of e-prescribing software in the Electronic Health Record (EHR) solutions.

E-prescribing or electronic prescribing is a new technologic infrastructure that helps the medical professionals to write and send prescriptions directly to the pharmacy.

Fortune Business Insights, in its recent report, titled, “E-prescribing Market Size, Share & Industry Analysis, By Delivery Mode (Web-based, On-premise), By Prescription Type (Controlled substance, Non controlled Substances) By End User (Hospitals, Physician's offices, Pharmacies) and Regional Forecast, 2019-2026,” states that the value of the market was USD 863.64 million in 2018 and will exhibit a CAGR of 21.0% during 2019 to 2026.For more information in the analysis of this report, visit:  https://www.fortunebusinessinsights.com/e-prescribing-market-102698The current outbreak of the COVID-19 pandemic has stirred the global economy.

Most of the international trade is at halt now, while some are struggling to generate meagre revenues.

Governments of various nations have imposed safety regulations.

We hope to fall out of this situation to a better one soon.

collect
0
Avani Sable 2021-10-19
img

The global bovine lactoferrin market size is projected to reach USD 949.0 million by the end of 2027.

Technological advancements in manufacturing processes will have a positive impact on the growth of the overall market in the coming years.

According to a report published by Fortune Business Insights, titled “Bovine Lactoferrin Market Size, Share & COVID-19 Impact Analysis, By Product (Spray-dried, and Freeze-dried), By Application (Infant Formula, Pharmaceuticals, Dietary Supplements, Food, and Others), and Regional Forecast, 2020-2027,” the market was worth USD 546.6 million in 2019 and will exhibit a CAGR of 5% during the forecast period, 2020-2027.For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/bovine-lactoferrin-market-101656Lactoferrin is an anti-microbial that has the ability to fight severe diseases such as Crohn’s disease.

The product is said to boost the fight against intestinal ulcers and critical diseases such as hepatitis C. Accounting to its properties, lactoferrin is used to treat viral infections.

The substance is found in human milk like colostrum, the first milk produced after the baby is born.

Due to several advantages of the product with regard to human health, bovine lactoferrin is being studied on a wider scale across the world.

collect
0
Avani Sable 2021-10-14
img

The global drug eluting stents (DES) market size is forecast to reach USD 8.98 billion by 2026, attributable to the increasing prevalence of cardiovascular diseases worldwide.

A drug eluting stent is a semi-rigid device in the form of a tube that is coated with a drug that helps to prevent reoccurrence or restenosis of an arterial blockage when released.

They help to reduce restenosis cases and also limits the risk of late or early thrombosis in patients.For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/drug-eluting-stent-des-market-102612More information on the market is provided in a recently published report by Fortune Business Insights™ titled, “Drug Eluting Stents (DES) Market Size, Share & Industry Analysis, By Type (Coronary Stenting, and Peripheral Stenting), By Product (Polymer-based, and Polymer-free), By Scaffold (Cobalt-Chromium, Platinum-Chromium, Nitinol and Others), By Drug (Sirolimus, Paclitaxel, Zotarolimus, Everolimus, and Others), By End User (Hospitals, and Specialty Clinics), and Regional Forecast, 2019-2026.” As per this report, the market value was USD 5.71 billion in 2019 and will exhibit a CAGR of 6.7% between 2019 to 2026.What is the Scope of the Report?The report offers a 360-degree overview of the market and its prime growth trajectories such as drivers, restraints, challenges, and upcoming opportunities.

It also discusses the market segment based on factors such as type, scaffold, drug, end-user, and regions.

It also provides market figures and CAGRs of the leading segments wit its attributed reasons.

Additionally, the report throws light on current drug eluting stents market trends, key industry developments, and other interesting insights.

collect
0
Avani Sable 2021-10-12
img

The global contraceptive pills market size is projected to reach USD 20.55 billion by 2026, exhibiting a CAGR of 5.8% during the forecast period.

High degree of unfulfilled contraceptive needs in rural areas in emerging economies is expected to be one of the key drivers for the growth of this market.

Data gathered under the Demographic and Health Surveys (DHS) conducted between 2005 and 2014 in 52 developing countries revealed that around 8% to 38% of married rural women, aged between 15 and 49 years, faced unmet contraceptive needs.

The main reason for this gap is the lack of accessibility and local availability of birth-control pills in these areas.

To counter this, governments in many developing and underdeveloped countries are taking efforts to make these modern day medications more accessible and affordable to the rural populace.

This will effectively accelerate the oral contraceptives market growth during the forecast period.visit: https://www.fortunebusinessinsights.com/industry-reports/contraceptive-pills-market-101802 Fortune Business Insights™, in its report, titled “Contraceptive Pills Market Size, Share & Industry Analysis, By Type (Combination Pills and Progestin-only Pills), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel & NGO, and Others) and Regional Forecast, 2019-2026”, states that the value of this market stood at USD 13.11 billion in 2018Expeditious Need to Curb Population Growth to Feed Market DevelopmentAccording to the United Nations’ Department of Economic and Social Affairs, by 2030, world population will reach 8.6 billion and by 2050, it will be 9.8 billion.

collect
0
Avani Sable 2021-10-22
img

The global contraceptive pills market size is projected to reach USD 20.55 billion by 2026, exhibiting a CAGR of 5.8% during the forecast period.

High degree of unfulfilled contraceptive needs in rural areas in emerging economies is expected to be one of the key drivers for the growth of this market.

Data gathered under the Demographic and Health Surveys (DHS) conducted between 2005 and 2014 in 52 developing countries revealed that around 8% to 38% of married rural women, aged between 15 and 49 years, faced unmet contraceptive needs.

The main reason for this gap is the lack of accessibility and local availability of birth-control pills in these areas.

To counter this, governments in many developing and underdeveloped countries are taking efforts to make these modern day medications more accessible and affordable to the rural populace.

This will effectively accelerate the oral contraceptives market growth during the forecast period.For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/contraceptive-pills-market-101802 Fortune Business Insights™, in its report, titled “Contraceptive Pills Market Size, Share & Industry Analysis, By Type (Combination Pills and Progestin-only Pills), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel & NGO, and Others) and Regional Forecast, 2019-2026”, states that the value of this market stood at USD 13.11 billion in 2018.

Avani Sable 2021-10-21
img

The global cosmeceuticals market size is projected to reach USD 73.73 billion by the end of 2026.

Increasing awareness among consumers regarding the advantages of cosmeceuticals over ordinary cosmetics will lead to a wider product adoption.According to a report published by Fortune Business Insights, titled “Cosmeceuticals Market Size, Share & Industry Analysis, By Product (Skin Care, Hair Care, Injectables and Others), By Distribution Channels (Pharmacy/Drug Stores, Online Stores, and Others), and Regional Forecast, 2019-2026,” the market was worth USD 37.41 billion in 2018 and will exhibit a CAGR of 8.9% during the forecast period, 2019-2026.For more information in the analysis of this report, visit:https://www.fortunebusinessinsights.com/cosmeceuticals-market-102521Product Overview:Cosmeceuticals are a combination of cosmetic product and pharmaceuticals.

They are mainly used in enhancing the physical appearance of the body and enhance skin health.

The demand for visually appealing lifestyle and changing habits will lead to a wider adoption of cosmeceuticals across the world.

The presence of several large scale vendors will emerge in favor of the growth of the overall cosmeceuticals market.

The availability of cosmeceuticals at a low cost will contribute to market growth.Little Optimism for SMEs; Extended Lockdowns Doing More Damage than Earlier PredictionsAs Covid-19 cases continue to rise, businesses are doing their best to adopt strategies that will help them run through online platforms, be it marketing or even distribution of the product.

Avani Sable 2021-10-20
img

The global medical lasers market will witness considerable growth due to growing applications of medical lasers in surgical procedures.

According to a report published by Fortune Business Insights, titled “Medical Lasers: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 3,778.9 Mn in 2018.

Fortune Business Insights has predicted that the market will reach US$ 12,327.8 Mn by 2026, thereby exhibiting a CAGR of 15.9%.For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/medical-lasers-market-101071The ability of medical lasers to treat damaged or targeted tissues, through a minimally invasive procedure, has led to a huge demand across the world.

Medical lasers possess the ability to diagnose and treat several diseases, which in turn will lead to a rising adoption across the world.

The use of laser radiation comes with certain challenges; recent scientific advancements will favor the growth of the global medical lasers market in the forthcoming years.

Resulting from the high demand, there have been numerous technological advancements in the manufacture of these equipment and this, according to Fortune Business Insights will constitute an increase in the global medical lasers market value in the forthcoming years.

Avani Sable 2021-10-19
img

The global pressure ulcer (PU) treatment market is expected to gain momentum from the rising adoption of innovative wound care devices for treatment.

As per the Agency for Healthcare Research & Quality (AHRQ), in the U.S., more than 2.5 million people get affected by pressure ulcers annually.

It proves that the increasing geriatric population, coupled with upsurging cases of PU would affect the market positively in the coming years.For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/pressure-ulcer-treatment-market-102095This information is provided by Fortune Business Insights™ in a recent study, titled, “Pressure Ulcer (PU) Treatment Market Size, Share & Industry Analysis, By Ulcer Type (Stage 1, Stage 2, Stage 3, Stage 4), By Product (Wound-care Dressings, Wound-care Devices, and Others), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Homecare Settings), and Regional Forecast, 2019-2026.” The study further states that the pressure ulcer treatment market size is projected to reach USD 11.23 billion by 2026, thereby exhibiting a CAGR of 6.7% during the forecast period.

However, it stood at USD 6.69 billion in 2018.The Report Answers the Following Questions:What are the most vital pressure ulcer market trends, opportunities, and challenges?How many growth drivers and hindrances will the market face?Which region will remain at the forefront throughout the forecast period?Which segment will dominate in terms of share?What are the strategies adopted by renowned companies to increase sales?DriverRising Patent Pool Worldwide to Augment GrowthIn the 20th century, a pressure ulcer was considered to be one of the costliest and the most physically debilitating complications.

Factors, such as mobility problems, sedentary lifestyle, advancing age, and other similar health issues are mainly responsible for surging the incidence of PU worldwide.

The National Center for Biotechnology Information (NCBI) declared that in 2018, the prevalence of pressure ulcers in Ethiopia, Turkey, and Brazil was 16%, 10.4%, and 12.7%, respectively.

Avani Sable 2021-10-18
img

The rapid adoption of electronic medical records and electronic health records by companies across the world drives the global revenue cycle management market or RCM market.

Fortune Business Insights in its new report, titled “Revenue Cycle Management: Global Market Analysis, Insights and Forecast 2018-2025” predicts the market to grow at a remarkable rate during the forecast period.

North America is expected to contribute significantly towards the growth of the revenue cycle management market.Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/revenue-cycle-management-market-100275Some of the major companies that are present in the Global Revenue Cycle Management Market are;MicrosoftIBMDellMcKessonExperianAllscriptsAthenahealthGreenway HealthGeBBS Healthcare SolutionsZirMed, now part of WaystarEpic Systems CorporationGeneral Electric Manufacturing Company Cerner CorporationThe rising adoption of RCM among end users and presence of well-established healthcare infrastructure is expected to drive the RCM market in North America.

In addition to this, revenue cycle management solutions offer long-term benefits, which is a key reason behind its high uptake in the region.

Furthermore, the increasing presence of physicians and hospitals in North America will fuel the demand for revenue cycle management services in the coming years.According to studies, Asia Pacific is projected to exhibit a high growth in the global RCM market.

The growth is primarily attributable to the rising target population looking for medical claims and treatment.

Avani Sable 2021-10-14
img

The global compression therapy market size is projected to reach USD 4.51 billion by 2026, exhibiting a CAGR of 5.2% during the forecast period.

Rising prevalence of cancer will be a key growth driver for this market in the coming decade, finds Fortune Business Insights™ in its report, titled “Compression Therapy Market Size, Share and Industry Analysis By Product (Compression Garments {Compression Bandages, Compression Stockings, and Others}, Compression Pumps, and Others), By Application (Venous Leg Ulcer, Deep Vein Thrombosis (DVT), Lymphedema, and Others), By End User (Hospitals & Clinics, Nursing Care Centers, Home Care, and Others), and Regional Forecast, 2019-2026”.

The global disease burden of cancer, according to the International Agency for Research on Cancer (IARC), rose by an estimated 18.1 million new cases in 2018.For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/compression-therapy-market-102689Cancer therapy, especially for breast and prostate cancers, generally involves dissection of lymph nodes, which causes disruption in the filtering mechanism of the lymphatic system in the body.

As a result, lymph fluid accumulates and causes massive swelling of limbs or tissues, a condition known as lymphedema.

Worldwide prevalence of this condition, as reported by the National Institutes of Health, is around 250 million.

One of the most commonly used treatment options for lymphedema is compression therapy and with increasing incidence of this condition, the demand for these therapies is set to steadily rise.Healthy R Funding to Fuel the Market in North AmericaThe market size in North America stood at USD 1.05 billion in 2018 backed by concerted investment in healthcare research and development by the private and public sectors.

Avani Sable 2021-10-13
img

The increasing prevalence of respiratory diseases and alpha-1 antitrypsin deficiency among people worldwide is boosting the global plasma fractionation market, says Fortune Business Insights in a new study.

The report, titled “Plasma Fractionation: Global Market Analysis, Insights, and Forecasts 2018 to 2026,” offers insights into growth drivers and restraints impacting the plasma fractionation market.Browse Complete Report:https://www.fortunebusinessinsights.com/industry-reports/plasma-fractionation-market-101614Rise in Number of Diagnostic Centers for using Plasma Proteins as Therapeutics to Bode Well for MarketThe rising awareness about diseases because of the expansion of media and increasing number of diagnostic centers have increased the value of plasma fractionation.

This is a major factor boosting the overall market.

In addition to that, increasing investments made in designing of therapeutics for chronic diseases is also anticipated to drive the global market.

Besides this, the increasing popularity and usage of proteins derived from plasma for various treatments is presumed to bode well for the global market.However, high cost of fractionation and insufficient reimbursement policies may cause hindrance to the growth of the market.

This, accompanied by the emergence of recombinant alternatives may hamper the market in the long run.North America Emerges Dominant on Account of Better Healthcare InfrastructuresGeographically, the global market for plasma fractionation is dominated by North America at present.

Avani Sable 2021-10-12
img

The global bovine lactoferrin market size is projected to reach USD 949.0 million by the end of 2027.

Technological advancements in manufacturing processes will have a positive impact on the growth of the overall market in the coming years.

According to a report published by Fortune Business Insights, titled “Bovine Lactoferrin Market Size, Share & COVID-19 Impact Analysis, By Product (Spray-dried, and Freeze-dried), By Application (Infant Formula, Pharmaceuticals, Dietary Supplements, Food, and Others), and Regional Forecast, 2020-2027,” the market was worth USD 546.6 million in 2019 and will exhibit a CAGR of 5% during the forecast period, 2020-2027.For more Information: https://www.fortunebusinessinsights.com/industry-reports/bovine-lactoferrin-market-101656Lactoferrin is an anti-microbial that has the ability to fight severe diseases such as Crohn’s disease.

The product is said to boost the fight against intestinal ulcers and critical diseases such as hepatitis C. Accounting to its properties, lactoferrin is used to treat viral infections.

The substance is found in human milk like colostrum, the first milk produced after the baby is born.

Due to several advantages of the product with regard to human health, bovine lactoferrin is being studied on a wider scale across the world.

Avani Sable 2021-10-22
img

The global contact lenses market size is projected to reach USD 12.05 billion by 2026, exhibiting a CAGR of 4.8% during the forecast period.

However, the market was worth USD 8.35 billion in 2018.

This information is published in a recent report by Fortune Business Insights, titled, “Contact Lenses Market Size, Share & Industry Analysis, By Modality (Reusable and Disposable), By Design (Toric, Multi-Focal, and Spherical), By Distribution Channel (Retail Stores, Online Stores, and Ophthalmologists), and Regional Forecast, 2019-2026.” As per the report, rising per capita healthcare expenditure and increasing incidence of astigmatism and myopia are expected to affect the market positively.For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/contact-lenses-market-101775What Does the Report Contain?In-depth information regarding all the possible segments, including modality, design, distribution channel, and region.Elaborate analysis of several insights, namely, contact lenses market trends, opportunities, growth drivers, and hindrances.Latest industry developments, such as new product launches, mergers, acquisitions, partnerships, and agreements.Rising Prevalence of Ocular Disorders to Augment Market GrowthThe World Health Organization (WHO) stated that approximately 1.7 million people are affected by presbyopia and around 153 million people reside with uncorrected refractive errors around the world.

A rising prevalence of presbyopia worldwide is one of the main factors propeling the contact lenses market growth in the coming years.

Also, many people are affected by ocular disorders, which in turn, is expected to boost growth of the market.Spherical Segment to Dominate the Market Backed by High PrescriptionsIn terms of design, the market is segregated into spherical, multifocal, and toric.

Out of these, the spherical segment had generated 65.8% contact lenses market share in 2018 and was in the leading position.

Avani Sable 2021-10-21
img

The global e-prescribing market size is expected to touch USD 4,017.79 million by the end of 2026, attributable to the incorporation of e-prescribing software in the Electronic Health Record (EHR) solutions.

E-prescribing or electronic prescribing is a new technologic infrastructure that helps the medical professionals to write and send prescriptions directly to the pharmacy.

Fortune Business Insights, in its recent report, titled, “E-prescribing Market Size, Share & Industry Analysis, By Delivery Mode (Web-based, On-premise), By Prescription Type (Controlled substance, Non controlled Substances) By End User (Hospitals, Physician's offices, Pharmacies) and Regional Forecast, 2019-2026,” states that the value of the market was USD 863.64 million in 2018 and will exhibit a CAGR of 21.0% during 2019 to 2026.For more information in the analysis of this report, visit:  https://www.fortunebusinessinsights.com/e-prescribing-market-102698The current outbreak of the COVID-19 pandemic has stirred the global economy.

Most of the international trade is at halt now, while some are struggling to generate meagre revenues.

Governments of various nations have imposed safety regulations.

We hope to fall out of this situation to a better one soon.

Avani Sable 2021-10-20
img

The global psoriasis treatment market size is anticipated to touch USD 37,634.2 million by 2026 owing to the increasing number of psoriasis cases.

These include non-melanoma skin cancer, psoriatic arthritis, lung cancer, depression, metabolic syndrome, cardiac disorders, COPD (chronic obstructive pulmonary disease), and others.

It may also cause polycystic ovarian syndrome and pregnancy complications in women.

As per this report titled, “Psoriasis Treatment Market Size, Share and Industry Analysis By Drug Class (TNF Inhibitors, Interleukins, Others), By Type (Plaque Psoriasis, Psoriatic Arthritis, Others), By Route of Administration (Oral, Parenteral, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online pharmacies), and Regional Forecast 2019-2026,” According to this report, the market value stood at USD 18,378.0 million in 2018 and will exhibit a CAGR of 9.4% between 2019 to 2026.visit: https://www.fortunebusinessinsights.com/industry-reports/psoriasis-treatment-market-100600The emergence of COVID-19 has brought the world to a standstill.

We understand that this health crisis has brought an unprecedented impact on businesses across industries.

Rising support from governments and several companies can help in the fight against this highly contagious disease.

Avani Sable 2021-10-19
img

The global bovine lactoferrin market size is projected to reach USD 949.0 million by the end of 2027.

Technological advancements in manufacturing processes will have a positive impact on the growth of the overall market in the coming years.

According to a report published by Fortune Business Insights, titled “Bovine Lactoferrin Market Size, Share & COVID-19 Impact Analysis, By Product (Spray-dried, and Freeze-dried), By Application (Infant Formula, Pharmaceuticals, Dietary Supplements, Food, and Others), and Regional Forecast, 2020-2027,” the market was worth USD 546.6 million in 2019 and will exhibit a CAGR of 5% during the forecast period, 2020-2027.For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/bovine-lactoferrin-market-101656Lactoferrin is an anti-microbial that has the ability to fight severe diseases such as Crohn’s disease.

The product is said to boost the fight against intestinal ulcers and critical diseases such as hepatitis C. Accounting to its properties, lactoferrin is used to treat viral infections.

The substance is found in human milk like colostrum, the first milk produced after the baby is born.

Due to several advantages of the product with regard to human health, bovine lactoferrin is being studied on a wider scale across the world.

Avani Sable 2021-10-18
img

The global respiratory syncytial virus (RSV) therapeutics market size is estimated to showcase potential growth owing to its increasing adoption against the prevention and treatment of the disease, observes Fortune Business Insights™ in an upcoming report, titled, “Respiratory Syncytial Virus (RSV) Therapeutics Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Prophylaxis and Treatment), By End-user (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) and Regional Forecast, 2020-2027.” The respiratory syncytial virus (RSV) therapeutics market stood at USD 1,111.3 million in 2019.

It is projected to grow from USD 609.2 million in 2020 to USD 4,003.4 million in 2027 at a CAGR of 30.9% in the forecast period.For More Questions, Talk with Respiratory Syncytial Virus (RSV) Therapeutics Industry Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/respiratory-syncytial-virus-rsv-therapeutics-market-104668High Production Scale to Hinder Growth Opportunities in Global Pharmaceutical SpaceThe COVID-19 contagion is expected to drive the global pharmaceutical industry.

Enterprises across the world along with governments from several nations are contributing to the development and distribution of the vaccine.

However, the scale at which the production is assumed to take place is a major challenge for most of the renowned players.

At Fortune Business Insights™, we are providing actionable insights by closely studying multiple aspects of the current scenario.

We are also offering firsthand information on various market trends through our comprehensive research reports.New Product Launches from Key Players Helped Prophylaxis Segment Hold Largest Share In 2019Based on drug class, the prophylaxis segment led the market with the largest share in 2019.

Avani Sable 2021-10-14
img

The global drug eluting stents (DES) market size is forecast to reach USD 8.98 billion by 2026, attributable to the increasing prevalence of cardiovascular diseases worldwide.

A drug eluting stent is a semi-rigid device in the form of a tube that is coated with a drug that helps to prevent reoccurrence or restenosis of an arterial blockage when released.

They help to reduce restenosis cases and also limits the risk of late or early thrombosis in patients.For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/drug-eluting-stent-des-market-102612More information on the market is provided in a recently published report by Fortune Business Insights™ titled, “Drug Eluting Stents (DES) Market Size, Share & Industry Analysis, By Type (Coronary Stenting, and Peripheral Stenting), By Product (Polymer-based, and Polymer-free), By Scaffold (Cobalt-Chromium, Platinum-Chromium, Nitinol and Others), By Drug (Sirolimus, Paclitaxel, Zotarolimus, Everolimus, and Others), By End User (Hospitals, and Specialty Clinics), and Regional Forecast, 2019-2026.” As per this report, the market value was USD 5.71 billion in 2019 and will exhibit a CAGR of 6.7% between 2019 to 2026.What is the Scope of the Report?The report offers a 360-degree overview of the market and its prime growth trajectories such as drivers, restraints, challenges, and upcoming opportunities.

It also discusses the market segment based on factors such as type, scaffold, drug, end-user, and regions.

It also provides market figures and CAGRs of the leading segments wit its attributed reasons.

Additionally, the report throws light on current drug eluting stents market trends, key industry developments, and other interesting insights.

Avani Sable 2021-10-13
img

The increasing prevalence of respiratory diseases and alpha-1 antitrypsin deficiency among people worldwide is boosting the global plasma fractionation market, says Fortune Business Insights in a new study.

The report, titled “Plasma Fractionation: Global Market Analysis, Insights, and Forecasts 2018 to 2026,” offers insights into growth drivers and restraints impacting the plasma fractionation market.Browse Complete Report:https://www.fortunebusinessinsights.com/industry-reports/plasma-fractionation-market-101614Rise in Number of Diagnostic Centers for using Plasma Proteins as Therapeutics to Bode Well for MarketThe rising awareness about diseases because of the expansion of media and increasing number of diagnostic centers have increased the value of plasma fractionation.

This is a major factor boosting the overall market.

In addition to that, increasing investments made in designing of therapeutics for chronic diseases is also anticipated to drive the global market.

Besides this, the increasing popularity and usage of proteins derived from plasma for various treatments is presumed to bode well for the global market.However, high cost of fractionation and insufficient reimbursement policies may cause hindrance to the growth of the market.

This, accompanied by the emergence of recombinant alternatives may hamper the market in the long run.North America Emerges Dominant on Account of Better Healthcare InfrastructuresGeographically, the global market for plasma fractionation is dominated by North America at present.

Avani Sable 2021-10-12
img

The global contraceptive pills market size is projected to reach USD 20.55 billion by 2026, exhibiting a CAGR of 5.8% during the forecast period.

High degree of unfulfilled contraceptive needs in rural areas in emerging economies is expected to be one of the key drivers for the growth of this market.

Data gathered under the Demographic and Health Surveys (DHS) conducted between 2005 and 2014 in 52 developing countries revealed that around 8% to 38% of married rural women, aged between 15 and 49 years, faced unmet contraceptive needs.

The main reason for this gap is the lack of accessibility and local availability of birth-control pills in these areas.

To counter this, governments in many developing and underdeveloped countries are taking efforts to make these modern day medications more accessible and affordable to the rural populace.

This will effectively accelerate the oral contraceptives market growth during the forecast period.visit: https://www.fortunebusinessinsights.com/industry-reports/contraceptive-pills-market-101802 Fortune Business Insights™, in its report, titled “Contraceptive Pills Market Size, Share & Industry Analysis, By Type (Combination Pills and Progestin-only Pills), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel & NGO, and Others) and Regional Forecast, 2019-2026”, states that the value of this market stood at USD 13.11 billion in 2018Expeditious Need to Curb Population Growth to Feed Market DevelopmentAccording to the United Nations’ Department of Economic and Social Affairs, by 2030, world population will reach 8.6 billion and by 2050, it will be 9.8 billion.